Bright Health Group, Inc., the value-driven, technology-driven healthcare company, today announced that it has entered into a definitive agreement with Molina Healthcare, Inc. (“Molina”), for the sale of California Medicare Advantage, Brand New Day and the Central Health Plan business, for a total purchase price of $600 million. At the […]
Featured News
Bristol Myers Squibb Receives European Commission Approval of CAMZYOS, for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol Myers Squibb announces that the European Commission has approved CAMZYOS® for the treatment of symptomatic hypertrophic obstructive cardiomyopathy in adult patients. CAMZYOS is the first and only reversible and allotropic Selective Cardiac Myosin Inhibitor approved in all Member States of the European Union* and the first Cardiac Myosin Inhibitor […]
VBA Announces Partnership With MPX to Provide Healthcare Payers With an Integrated Solution for Communications Management
VBA announced today its partnership with MPX to offer a solution for high-touch communications by integrating the HealthLinq® portal with VBASoftware and VBAGateway for a seamless payer experience. Integration with VBASoftware provides registrations, claims, permissions, and other data needed to support communication between members and vendors without managing file workflows. Integration […]
Vaxxas Opens World-Class Manufacturing Facility To Produce Proprietary Needle-Free Vaccine Patch For Late-Stage Clinical Trials and First Commercial Products
Vaxxas, a clinical-stage biotech company commercializing new vaccine platform technology, today announced the opening of its first state-of-the-art manufacturing facility in Brisbane, Queensland. The purpose-built 5,500-square-foot (60,000 square foot) Vaxxas Biomedical Facility will serve as the company’s global headquarters and support its expansion to produce HD-MAP vaccines for prospective late-stage […]
TheMathCompany Partners with Komodo Health to Enhance Patient Outcomes with Advanced Insights
TheMathCompany, based in Illinois, a leading global data analytics and engineering company, announced a partnership with health technology company, Komodo Health. Through this partnership, TheMathCompany will have access to Komodo’s technology platform, powered by Healthcare Map – the most comprehensive and accurate source of anonymous patient-level data available – to […]
Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old
Ironwood Pharmaceuticals, Inc., a gastrointestinalfocused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved LINZESS® (linaclotide) as a method of treatment. once-daily treatment of dysfunctional pediatric patients 6 to 17 years of age. constipation. LINZESS is the first and only FDA-approved prescription treatment for functional […]
Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship
Allergan Aesthetics, the maker of onabotulinumtoxinA (Botox), has partnered with IFundWomen to ensure women entrepreneurs can apply for $25,000 funding, coaching and mentoring. The partnership, announced on International Women’s Day (March 8), aims to fill a gap in the beliefs of rising women. Allergan Aesthetics leaders say they are committed […]
Clean Cells begins activities in the largest biopharmaceutical testing site in Europe
Clean Cells has launched analytical operations at its new €22 million ($24.1 million) plant based in Montaigu-Vendée. Clean Cells is part of the Clean Biologics Group, a supplier of quality control services to biopharmaceuticals and manufacturers of raw materials. The site offers four times more lab space than the previous […]
GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare announced today at the European Congress of Radiology (ECR) in Vienna, Austria that it has completed the registration of Phase I subjects in the initial clinical development program for circumferential magnetic resonance imaging. Manganese-based large-scale, the first contrast agent of its kind (MRI). agency. Typically, MRI agents – […]
Ascelia Pharma Meets Major Milestone With Patient Enrollment Completion For Orviglance Phase 3 Study, Sparkle
Ascelia Pharma AB, a biotech company focused on improving the lives of people with rare cancers, today announced the successful completion of patient enrollment in a clinical study. SPARKLE’s Phase 3 clinical trial with the main drug candidate Orviglance. “We are very pleased to have reached our enrollment target of […]
